Taysha Gene TherapiesÂ Inc (TSHA) Financials

$4.73

$-0.06 (-1.25%)

As on 25-Sep-2026 13:34EDT

Market cap

$1,636 Mln

Revenue (TTM)

$5 Mln

P/E Ratio

--

P/B Ratio

4.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	5.49	9.77	8.33	15.45	2.50	--
Cost of Revenue	0.88	1.15	1.25	1.37	2.49	0.49
Gross Profit	4.61	9.77	8.33	15.45	0.01	-0.49
Operating Expenses	157.76	120.27	99.79	87.89	126.04	173.27
Operating Profit (EBIT)	-153.16	-110.50	-91.46	-72.44	-126.03	-173.27
Other Income	--	--	--	--	--	--
Profit before Tax	-149.63	-109.00	-89.30	-111.57	-166.01	-174.52
Provision for Tax	--	--	-89.30	1.20	3.57	0.94
Profit after Tax (Net Income)	-149.63	-109.00	-89.30	-111.57	-166.01	-174.52
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-174.52

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	387.27	246.94	71.53	74.94	0.95	95.38
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	57.19	69.83	62.61	61.04	62.54	66.83
Current Liabilities	25.98	26.55	26.23	36.76	62.79	51.75
Total Liabilities	496.41	343.32	160.36	172.73	126.28	213.96

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	9.00	18.67	18.23	22.86	29.86	54.35
Current Assets	461.43	324.65	142.13	149.87	96.42	159.60
Total Assets	496.41	343.32	160.36	172.73	126.28	213.96
Total Debt*	55.55	18.17	63.18	61.11	59.93	63.09
Net Current Assets	435.46	298.10	115.90	113.11	33.63	107.86

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-93.09	-81.23	-73.02	-88.39	-117.04
Cash Flow from Investing Activities	--	-0.60	-0.36	-7.35	-24.93	-21.55
Cash from Financing Activities	--	274.59	76.68	136.39	52.10	39.08
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.42	-0.34	-0.44	-0.60	-2.94	-4.58
Cash EPS ($)	--	-0.34	-0.43	-0.59	-2.92	-4.57
Adjusted Book Value ($)	--	0.77	0.35	0.40	0.02	2.50
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.29	-0.40	-0.39	-1.57	-3.07
Free Cash Flow per Share ($)	--	-0.29	-0.40	-0.43	-2.01	-3.64

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-54.52	-65.96	-113.31	-151.37	-85.18
ROE (%)	-47.19	-68.45	-121.94	-294.04	-344.67	-100.68
ROA (%)	-35.00	-43.28	-53.62	-74.62	-97.59	-73.82
EBIT Margin (%)	-2,735.68	-1,114.62	-1,070.39	-689.72	-6,483.45	--
Net Margin (%)	-2,728.04	-1,115.27	-1,071.62	-722.06	-6,635.25	--
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-32.27	0.17	-0.46	5.18	--	--
EBIT Growth (%)	-61.98	-22.13	16.30	34.30	6.28	-188.57
Net Profit Growth (%)	-61.38	-22.06	19.96	32.80	4.88	-305.87
EPS Growth (%)	-18.12	0.22	0.27	0.80	0.36	-3.02
Book Value Growth (%)	25.72	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-16.13	-3.97	-2.97	-0.77	-2.54
Price / Book Value	4.35	7.12	4.96	4.42	134.28	4.65
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.61	-13.52	-3.17	-2.36	-0.62	-2.07
Close Price ($)	6.81	5.50	1.73	1.77	2.26	11.65
High Price ($)	7.30	6.02	4.32	3.89	12.32	33.35
Low Price ($)	2.25	1.05	1.19	0.50	1.35	11.12
Market Cap ($ Cr)	1,635.68	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.13	0.07	0.88	0.82	63.15	0.66
Short term debt to equity ratio	--	--	0.03	0.02	1.60	--
Current Ratio	17.76	12.23	5.42	4.08	1.54	3.08
Quick Ratio	17.76	--	--	--	--	--
Interest Coverage	-3,561.69	-1,729.08	-874.47	-21.32	-42.71	-121.21

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.01	0.04	0.05	0.10	0.01	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	1,573.76	1,460.71	2,306.06	2,401.88	8,818.34
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.